NLRP12 and gastric cancer: To further clarify that NLRP12 promotes gastric cancer proliferation through HK2-mediated glycolysis, we employed both pharmacological inhibition (2-DG, a competitive HK2 inhibitor) and genetic silencing (shRNA-mediated HK2 knockdown).